Altus Therapeutics has officially called a halt to a supply agreement with contract manufacturer Lonza in the latest round of …
Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …
A lawyer once told me that the law has nothing to do with morals. This wasn’t really a surprise, but …
Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …
Rock Medical Communications has been launched as part of the Creston Health group. The company will deliver medical education programmes, …
PPD has cancelled plans to occupy a facility at the North Carolina Research Campus in the US, blaming construction delays …
The public has grave fears over the future of NHS funding in light of the recession, according to a public …
Pharmafocus presents a round-up of developments in the contract research sector, including a successful IPO by Medidata, Pierrel's imminent acquisition …
Medical education agency Succinct Communications has launched a sister company, Succinct Consulting. Succinct Consulting says it will help international pharmaceutical …
Regulatory pressures are at the top of the list of supply chain concerns voiced by pharmaceutical manufacturers in an annual …
GPs and practice nurses are to be targeted in a government awareness campaign to ensure cervical cancer is spotted earlier …
Japan has approved its first biosimilar medicine – the recombinant human growth hormone somatropin from Novartis' generic arm Sandoz. The …
Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …
GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …
US biotechnology company Dendreon revealed its confidence in lead drug Provenge for prostate cancer with the announcement it will invest …
Drug makers have agreed with the US government to spend $80 billion over the next ten years in a bid …
Pharmaceutical group Helsinn is planning to expand its manufacturing capabilities with a new round of investment at a production facility …
How did you find your way into your current role?I have worked for several years in the Canadian pharmaceutical industry …